Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • allogeneic haematopoietic stem cell transplant

    - PMLiVE

    UK and US agree on landmark pharma pricing tariff deal

    US tariffs on UK-produced pharmaceuticals will remain at zero for three years

    - PMLiVE

    ViiV Healthcare receives NICE recommendation for HIV prevention therapy

    The treatment is the first and only long-acting HIV prevention option available on the NHS in England and Wales

    - PMLiVE

    New National Commission launched to strengthen AI regulation

    The Commission will unite healthcare leaders, regulators and technology experts to shape future AI governance

    - PMLiVE

    NHS programme to give head and neck cancer patients fast-track access to mRNA vaccine

    More than 11,000 people are diagnosed with head and neck cancers every year in England

    - PMLiVE

    NICE recommends BeOne’s Brukinsa to treat mantle cell lymphoma on NHS

    Approximately 600 people are affected by the form of non-Hodgkin lymphoma every year in the UK

    - PMLiVE

    UK government publishes 10 Year Health Plan for England to ‘reinvent’ NHS

    The plan’s three overarching themes are hospital to community, analogue to digital and sickness to prevention

    - PMLiVE

    Novartis shares positive late-stage results for Fabhalta in rare blood disorder PNH

    Paroxysmal nocturnal haemoglobinuria affects approximately ten to 20 people per million worldwide

    - PMLiVE

    NHS patients to access Theramex’s endometriosis pill following NICE recommendation

    The once-a-day drug has been recommended for patients with a history of previous medical or surgical treatment

    - PMLiVE

    NHS programme to give melanoma patients fast-track access to skin cancer vaccine

    The phase 2 study will evaluate Scancell's iSCIB1+ in patients with advanced unresectable melanoma

    - PMLiVE

    Prime minister unveils UK government’s plans to abolish NHS England

    The move aims to cut waiting times and free up money for front-line services

    - PMLiVE

    World Kidney Day – Boehringer launches CKD initiative to tackle UK health inequalities

    Approximately 10% of the UK population is affected by chronic kidney disease

    - PMLiVE

    UK access pathway launched to get new medicines to patients in ‘shortest time possible’

    The ILAP offers drug developers a single platform to collaborate with the MHRA and HTA bodies

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links